Dietary Protein Reduction During Isocaloric Conditions Reduces Body Weight in Men With Overweight or Obesity

ABSTRACT Objective Dietary protein reduction increases plasma fibroblast growth factor 21 (FGF21) and energy requirements in lean men under eucaloric conditions. Whether these metabolic effects translate to weight loss during isocaloric conditions in men with overweight or obesity remains unclear. Methods Seventeen men with overweight or obesity were randomly allocated to two different highly controlled, isocaloric diets for 5 weeks, receiving either a protein‐reduced diet (0.9 g kg −1 BW day −1 ) substituted with increased carbohydrates or a habitual diet (1.8 g kg −1 BW day −1 ). Results Protein reduction induced a 2.0 ± 0.6 kg weight loss and increased plasma FGF21 concentration compared with higher protein intake, without caloric restriction. Changes in plasma FGF21 concentration were inversely associated with changes in body weight ( r = −0.59, p = 0.02). Expression of key components in the FGF21 receptor complex, FGFR1 and β‐klotho, and downstream targets in subcutaneous adipose tissue remained unchanged. Markers of skeletal muscle mitochondrial oxidative phosphorylation were also unaltered. Fat mass decreased significantly, whereas this level of protein reduction only tended to lower lean body mass. Conclusions These findings suggest that reducing protein intake (0.9 g kg −1 BW day −1 ), substituted with increased carbohydrates, compared with a habitual protein intake (1.8 g kg −1 BW day −1 ), can induce weight loss without restricting total energy intake in men with overweight or obesity. Trial Registration ClinicalTrials.gov identifier: NCT06263725 image

Authors

Institutions

Publication Details

Journal
Obesity
Published
2026-06-16
DOI
https://doi.org/10.1002/oby.70248
Primary Topic
Fibroblast Growth Factor Research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Dietary Protein Reduction During Isocaloric Conditions Reduces Body Weight in Men With Overweight or Obesity

Andreas M. Fritzen, N M Andersen, Bente Kiens, Aslak Emil Lyster et al.
Obesity
Fibroblast Growth Factor Research
article

Dietary Protein Reduction During Isocaloric Conditions Reduces Body Weight in Men With Overweight or Obesity

Andreas M. Fritzen, N M Andersen, Bente Kiens, Aslak Emil Lyster, Jacob K. Jensen, K Jørgensen, Lukas Nachtigall, A S Frederiksen, Erik A. Richter, Daniela Weber, Annemarie Lundsgaard
article en

Abstract

ABSTRACT Objective Dietary protein reduction increases plasma fibroblast growth factor 21 (FGF21) and energy requirements in lean men under eucaloric conditions. Whether these metabolic effects translate to weight loss during isocaloric conditions in men with overweight or obesity remains unclear. Methods Seventeen men with overweight or obesity were randomly allocated to two different highly controlled, isocaloric diets for 5 weeks, receiving either a protein‐reduced diet (0.9 g kg −1 BW day −1 ) substituted with increased carbohydrates or a habitual diet (1.8 g kg −1 BW day −1 ). Results Protein reduction induced a 2.0 ± 0.6 kg weight loss and increased plasma FGF21 concentration compared with higher protein intake, without caloric restriction. Changes in plasma FGF21 concentration were inversely associated with changes in body weight ( r = −0.59, p = 0.02). Expression of key components in the FGF21 receptor complex, FGFR1 and β‐klotho, and downstream targets in subcutaneous adipose tissue remained unchanged. Markers of skeletal muscle mitochondrial oxidative phosphorylation were also unaltered. Fat mass decreased significantly, whereas this level of protein reduction only tended to lower lean body mass. Conclusions These findings suggest that reducing protein intake (0.9 g kg −1 BW day −1 ), substituted with increased carbohydrates, compared with a habitual protein intake (1.8 g kg −1 BW day −1 ), can induce weight loss without restricting total energy intake in men with overweight or obesity. Trial Registration ClinicalTrials.gov identifier: NCT06263725 image

Obesity
University of Copenhagen (DK), University of Potsdam (DE), German Institute of Human Nutrition (DE)
Danmarks Frie Forskningsfond, Novo Nordisk Fonden
Affordable and clean energy
Openalex Percentile: Top 12%
Fibroblast Growth Factor Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.